Osteoporosis is a skeletal disorder characterized by low bone mass and deterioration of bone tissue, currently affecting nearly 200 million individuals worldwide. The disease leads to increased bone fragility and fracture risk of hip, spine, forearm and shoulder. In Europe alone, at least one in three women and one in eight men over the age of 50 will sustain an osteoporotic fracture in their lifetime.
Our aim is to improve treatment of the most common of all osteoporotic fractures: the Vertebral Compression Fracture (VCF). Vertebrae (spinal bones) are the building blocks of the spinal column. Loss of body height and a bent posture are visible signs of the condition. People suffering from vertebral compression fractures tend to become less mobile, and regularly suffer from associated problems like decreased appetite, sleep disorders, low self esteem, diminished social interaction and loss of independence. High doses of pain medication, especially narcotic drugs, further limit functional ability in daily life.
Call for proposal
See other projects for this call
Funding SchemeCooperative - SMEs-Co-operative research contracts